Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiomyopathy
Biotech
FDA puts Tenaya heart disease gene therapy trial on hold
The FDA has put a hold on the study while the biotech works to standardize activities related to the immunosuppression regimen across trial sites.
Nick Paul Taylor
Nov 10, 2025 5:16am
Braveheart, with Biogen CEO on board, rallies $185M series A
Nov 5, 2025 7:51am
Cytokinetics’ ph. 3 cardio win sends stock soaring
Sep 2, 2025 2:05pm
Rocket's gene therapy sets new efficacy bar in ph. 1 heart study
May 16, 2025 10:36am
Edgewise claims heart pressure reductions for Camzyos rival
Apr 2, 2025 8:45am
BMS' MyoKardia scraps heart muscle pact with Fulcrum
Mar 5, 2025 5:30am
